Distal embolization during angioplasty for acute myocardial infarction: is pharmacological protection enough?
De Carlo
Marco
M
Cardio-Thoracic Department, University of Pisa, Italy. m_decarlo@tiscali.it
Limbruno
Ugo
U
Pistolesi
Sabina
S
Fontanini
Gabriella
G
Petronio
Anna S
AS
Balbarini
Alberto
A
De Caterina
Raffaele
R
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003331:Coronary Vessels; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D015912:Thrombolytic Therapy
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab